Related Experiment Video
Updated: Jun 1, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Benzodiazepine use and misuse among patients in a methadone program
Kevin W Chen1, Christine C Berger, Darlene P Forde
1Center for Integrative Medicine University of Maryland School of Medicine 520 W, Lombard St, East Hall, Baltimore, MD 21201, USA. kchen@compmed.umm.edu
Benzodiazepine (BZD) misuse is prevalent in methadone programs, with many patients starting or increasing use after enrollment. This highlights a need for integrated anxiety and addiction treatment.
Area of Science:
- Addiction Medicine
- Psychiatry
- Public Health
Background:
- Benzodiazepine (BZD) misuse poses significant public health risks, particularly for opiate-dependent patients with anxiety in methadone programs.
- Co-occurring anxiety and BZD misuse increase relapse risk for individuals in recovery.
Purpose of the Study:
- To estimate the prevalence of BZD misuse among patients in a methadone program.
- To identify factors associated with BZD misuse in this population.
Main Methods:
- Anonymous surveys were administered to patients at a methadone program in Baltimore, MD.
- 194 completed questionnaires were analyzed from a voluntary participant pool.
Main Results:
- 47% of respondents reported a history of BZD use, with 39.8% using without a prescription.
- BZD users were more likely to be White, have prescribed mental health medications, and have pre-existing anxiety.
- BZD users reported higher rates of anxiety, depression, and perceived stress.
Conclusions:
- Methadone programs may not adequately address co-occurring anxiety, potentially contributing to BZD misuse.
- Further research is needed to develop integrated treatments for addiction, anxiety, and BZD misuse.
More Related Videos
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Abuse and Addiction: Pharmacological Phenomena
Sedatives and Hypnotics Drugs: Barbiturates
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...